Hiroyasu Yamashiro
- Cancer Research top 10%
- Breast Cancer Treatment Studies 14
- Oncology top 10%
- Cancer Treatment and Pharmacology 16
- HER2/EGFR in Cancer Research 15
- Genetics top 10%
- Mesenchymal stem cell research 5
- Surgery top 10%
- Breast Implant and Reconstruction 5
- Dermatology top 5%
- Chemotherapy-related skin toxicity 4
-
- Electrospun Nanofibers in Biomedical Applications 5
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Katsumasa KuroiTetsuya TaguchiShinya SaitoHirohisa ImaiKojiro ShimozumaMasakazu ToiShozo OhsumiTakashi Inamoto
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- Journal of Clinical Oncology (1 paper)Cancer Research (1 paper)Scientific Reports (1 paper)
- Partner nations
- JapanSwitzerlandUnited States
In The Last Decade
Hiroyasu Yamashiro
35 papers receiving 807 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 256
- Oncology 270
- Genetics 104
- Surgery 419
- Dermatology 77
Countries citing papers authored by Hiroyasu Yamashiro
This map shows the geographic impact of Hiroyasu Yamashiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyasu Yamashiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyasu Yamashiro more than expected).
Fields of papers citing papers by Hiroyasu Yamashiro
This network shows the impact of papers produced by Hiroyasu Yamashiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyasu Yamashiro. The network helps show where Hiroyasu Yamashiro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroyasu Yamashiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 1 | |
| 3 | 2020 | 5 | |
| 4 | 2019 | 61 | |
| 5 | 2018 | 18 | |
| 6 | 2016 | 2 | |
| 7 | 2015 | 1 | |
| 8 | 2015 | 4 | |
| 9 | 2013 | 0 | |
| 10 | 2013 | 1 | |
| 11 | 2012 | 32 | |
| 12 | 2011 | 17 | |
| 13 | [Molecular targeted therapy for breast cancer treatment, challenge to cure]. | 2010 | 3 |
| 14 | 2009 | 4 | |
| 15 | 2009 | 28 | |
| 16 | 2008 | 46 | |
| 17 | 2008 | 17 | |
| 18 | 2006 | 139 | |
| 19 | 2005 | 121 | |
| 20 | 2004 | 18 |
About Hiroyasu Yamashiro
Hiroyasu Yamashiro is a scholar working on Cancer Research, Oncology and Genetics, having authored 38 papers that have together received 836 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (16 papers), HER2/EGFR in Cancer Research (15 papers), Breast Cancer Treatment Studies (14 papers), Mesenchymal stem cell research (5 papers), Electrospun Nanofibers in Biomedical Applications (5 papers), Breast Implant and Reconstruction (5 papers), Advanced Breast Cancer Therapies (4 papers) and Chemotherapy-related skin toxicity (4 papers). The work is most often cited by research in Cancer Research (256 citations), Oncology (270 citations) and Genetics (104 citations). Hiroyasu Yamashiro has collaborated with scholars based in Japan, Switzerland and United States. Frequent co-authors include Katsumasa Kuroi, Tetsuya Taguchi, Shinya Saito, Hirohisa Imai, Kojiro Shimozuma, Masakazu Toi, Shozo Ohsumi, Takashi Inamoto, Yasuhiko Tabata and Yu Kimura. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.